List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 175 studies with search of:   "Lenalidomide"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Multi-Center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia;   CLL;   Untreated;   Front-Line;   First-Line;   Initial Therapy
Interventions: Drug: Lenalidomide and Rituximab;   Drug: Lenalidomide and Rituximab
2 Recruiting Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
Condition: Cutaneous Lupus Erythematosus (CLE)
Intervention: Drug: lenalidomide (Revlimid®)
3 Active, not recruiting A Study of Revlimid for Treatment of Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin's
Interventions: Drug: lenalidomide;   Drug: lenalidomide
4 Recruiting Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Intervention: Drug: lenalidomide-low dose dexamethasone plus rituximab
5 Recruiting Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)
Condition: Graft-Versus-Host Disease
Intervention: Drug: Lenalidomide
6 Not yet recruiting Study to Determine Efficacy and Safety of Lenalidomide Plus Low-Dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide and low-dose dexamethasone;   Drug: Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles;   Drug: Melphalan, Prednisone and Thalidomide
7 Recruiting Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
Condition: Malignant Gliomas
Interventions: Drug: Irinotecan;   Drug: Lenalidomide
8 Completed Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: Lenalidomide;   Drug: Dacarbazine
9 Completed Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
Condition: Complex Regional Pain Syndrome, Type I
Interventions: Drug: lenalidomide (CC-5013);   Drug: Placebo
10 Recruiting Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide
11 Recruiting Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis
Condition: Amyloidosis
Interventions: Drug: cyclophosphamide;   Drug: lenalidomide;   Drug: dexamethasone
12 Recruiting Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide (Revlimid®)
13 Terminated A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Condition: B-Cell Lymphoma
Intervention: Drug: CC-5013 (lenalidomide)
14 Recruiting A Study of Oral CC-5013 (Lenalidomide; Revlimid) in Myelodysplastic Syndromes
Condition: Myelodysplastic Syndrome (MDS)
Interventions: Drug: Lenalidomide (CC-5013);   Drug: Erythropoietin (rhu-EPO)
15 Recruiting Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malig Who Relapse/Progress After Rituximab
Conditions: Lymphocytic Leukemia;   Mantle Cell Lymphoma
Intervention: Drug: Lenalidomide (REVLIMID®)
16 Recruiting Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Lenalidomide;   Drug: Rituximab
17 Recruiting Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
Conditions: Advanced Cancer;   Pain
Intervention: Drug: Lenalidomide
18 Recruiting Study Role of Lenalidomide in Improving Sleep in CLL Patients 65+ Years Experiencing Clinically Significant Fatigue
Conditions: Leukemia;   CLL
Intervention: Drug: Lenalidomide
19 Active, not recruiting Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia;   Leukemia
Intervention: Drug: Lenalidomide (Revlimid)
20 Recruiting Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
Interventions: Drug: Lenalidomide;   Drug: Rituximab

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services